Literature DB >> 16598395

Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patients.

F Picard1, M Brehm, M Fassbach, B Pelzer, S Scheuring, P Küry, B E Strauer, B Schwartzkopff.   

Abstract

Left ventricular dilation and myocardial remodeling are hallmarks of dilated cardiomyopathy (DCM). It is assumed that left ventricular dilation is caused by the disintegration of the collagenous network by increased collagenolytic activity of matrix metalloproteinases (MMPs) and their adequate tissue inhibitors (TIMPs). In this study the myocardial MMP-1 and TIMP-1 mRNA expressions were investigated by using real-time quantitative PCR analysis from right septal endomyocardial biopsies of patients with dilated cardiomyopathy (n = 46) and control subjects (n = 11). The volume density (Vv%) of collagen was measured morphometrically. Classification was done according to LV diameters [left ventricular enddiastolic diameter (LVEDD, cm) calculated to body surface area (BSA, m(2))] into three DCM groups: group I (LVEDD-BSA > 2.7-3.0 cm/m(2)), group II ( > 3.0-3.6 cm/m(2)), group III ( > 3.6 cm/m(2)), controls (< 2.7 cm/m(2)). Compared with controls, the MMP-1 expression in patients with DCM was significantly increased (119.2 +/- 45.2 vs. 1.3 +/- 0.4; p < 0.001) as was TIMP-1 expression (9.6 +/- 1.2 vs. 1.3 +/- 0.4; p < 0.01). Moreover the MMP-1 and TIMP-1 expression varied according to LV diameter: group I (MMP-1: 8.7 +/- 3.5; p = 0.33; TIMP- 1: 4.5 +/- 1.2; p < 0.01); group II (MMP-1: 211.4 +/- 86.0; p < 0.001; TIMP-1: 12.5 +/- 1.9 ; p < 0.001); group III (MMP-1: 38.8 +/- 22.6; p < 0.01; TIMP-1: 8.1 +/- 1.7; p < 0.001). Compared with controls, the collagen level in DCMPt. was significantly increased: 5.0 +/- 0.6 vol% vs 1.2 +/- 0.2 vol% p < 0.001 and correlates with LV diameter. This study reveals that the overexpression of MMP-1, which is associated with an increased ratio of MMP-1/TIMP-1 in DCM, indicates an activated collagenolytic system while replacement fibrosis is accumulating. The MMP-1 overexpression is mainly found in moderately dilated DCM hearts (group II) indicating the dynamic process of LV dilation and the importance of collagenases in the early phase of LV remodeling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598395     DOI: 10.1007/s00392-006-0373-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   6.138


  40 in total

Review 1.  Remodeling and reparation of the cardiovascular system.

Authors:  K T Weber; P Anversa; P W Armstrong; C G Brilla; J C Burnett; J M Cruickshank; R B Devereux; T D Giles; N Korsgaard; C V Leier
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

Review 2.  Matrikines in the regulation of extracellular matrix degradation.

Authors:  F X Maquart; G Bellon; S Pasco; J C Monboisse
Journal:  Biochimie       Date:  2005 Mar-Apr       Impact factor: 4.079

3.  Successful cardiac resynchronization therapy in a 9-year-old boy with dilated cardiomyopathy.

Authors:  J-H Nürnberg; C Butter; H Abdul-Khaliq; M Schlegl; P E Lange
Journal:  Z Kardiol       Date:  2005-01

Review 4.  Extracellular matrix dynamics in heart failure: a prospect for gene therapy.

Authors:  S C Tyagi
Journal:  J Cell Biochem       Date:  1998-03-15       Impact factor: 4.429

5.  Differential gene expression of extracellular matrix components in dilated cardiomyopathy.

Authors:  S C Tyagi; S Kumar; D J Voelker; H K Reddy; J S Janicki; J J Curtis
Journal:  J Cell Biochem       Date:  1996-11-01       Impact factor: 4.429

6.  Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.

Authors:  U Kühl; M Noutsias; B Seeberg; H P Schultheiss
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

7.  A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.

Authors:  F G Spinale; M L Coker; L J Heung; B R Bond; H R Gunasinghe; T Etoh; A T Goldberg; J L Zellner; A J Crumbley
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

8.  Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.

Authors:  Rüdiger Becker; Markus Haass; Dirk Ick; Carsten Krueger; Alexander Bauer; Julia C Senges-Becker; Frederik Voss; Thomas Hilbel; Feraydoon Niroomand; Hugo A Katus; Wolfgang Schoels
Journal:  Basic Res Cardiol       Date:  2003-07       Impact factor: 17.165

9.  Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.

Authors:  F X Maquart; L Pickart; M Laurent; P Gillery; J C Monboisse; J P Borel
Journal:  FEBS Lett       Date:  1988-10-10       Impact factor: 4.124

10.  Embryogenesis of the rat heart: the expression of collagenases.

Authors:  Anna Ratajska; Jack P M Cleutjens
Journal:  Basic Res Cardiol       Date:  2002-05       Impact factor: 17.165

View more
  13 in total

1.  Plasma profiling determinants of matrix homeostasis in paediatric dilated cardiomyopathy.

Authors:  Tain-Yen Hsia; Jeremy M Ringewald; Robert E Stroud; Nadia Roessler; Nidhi Kumar; Scott T Reeves; Francis G Spinale
Journal:  Cardiol Young       Date:  2010-10-27       Impact factor: 1.093

2.  Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy.

Authors:  Tain-Yen Hsia; Jeremy M Ringewald; Robert E Stroud; Geoffrey A Forbus; Scott M Bradley; Wendy K Chung; Francis G Spinale
Journal:  Eur J Heart Fail       Date:  2010-12-08       Impact factor: 15.534

3.  Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension.

Authors:  Oliver Dörr; Christoph Liebetrau; Helge Möllmann; Felix Mahfoud; Sebastian Ewen; Luise Gaede; Christian Troidl; Jedrzej Hoffmann; Nikolai Busch; Gerald Laux; Jens Wiebe; Timm Bauer; Christian Hamm; Holger Nef
Journal:  Clin Res Cardiol       Date:  2014-10-18       Impact factor: 5.460

4.  Prevalence of ventricular discordance and its relation to functional capacity in idiopathic dilated cardiomyopathy.

Authors:  Gunnar Plehn; Julia Vormbrock; Lutz Lefringhausen; Marc van Bracht; Alexander Plehn; Thomas Butz; Hans-Joachim Trappe; Axel Meissner
Journal:  Clin Res Cardiol       Date:  2009-03-13       Impact factor: 5.460

5.  Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.

Authors:  Elia C El Hajj; Milad C El Hajj; Van K Ninh; Jason D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

6.  Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes.

Authors:  Tiam Feridooni; Adam Hotchkiss; Sarah Remley-Carr; Yumiko Saga; Kishore B S Pasumarthi
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

7.  Pathway reporter genes define molecular phenotypes of human cells.

Authors:  Jitao David Zhang; Erich Küng; Franziska Boess; Ulrich Certa; Martin Ebeling
Journal:  BMC Genomics       Date:  2015-04-24       Impact factor: 3.969

8.  Associations between Interleukin-31 Gene Polymorphisms and Dilated Cardiomyopathy in a Chinese Population.

Authors:  Huizi Song; Ying Peng; Bin Zhou; Nan Chen; Xiaochuan Xie; Qingyu Dou; Yue Zhong; Li Rao
Journal:  Dis Markers       Date:  2017-05-10       Impact factor: 3.434

9.  Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease.

Authors:  Dong Fan; Abhijit Takawale; Jiwon Lee; Zamaneh Kassiri
Journal:  Fibrogenesis Tissue Repair       Date:  2012-09-03

10.  Correlations of GDF-15 with sST2, MMPs, and worsening functional capacity in idiopathic dilated cardiomyopathy: Can we gain new insights into the pathophysiology?

Authors:  Nandini Nair; Enrique Gongora
Journal:  J Circ Biomark       Date:  2018-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.